Pharmaceuticals, Biotechnology and Life Sciences
Mereo BioPharma on Tuesday presented positive data after testing BGS-649, oral inhibitor aromatase treatment of hypogonadotropic hypogonadism (HH) for obese…
Verona Pharma started the second phase of clinically evaluating a dry powder inhaler (DPI) formulation of RPL554 in moderate to…
Alvogen’s Chairman & CEO Robert Wessman is the new Chairman of the Board at the publicly listed Lotus Pharmaceuticals in Taiwan, succeeding Andrew Lin. Lotus Pharmaceuticals, which is majority-owned by Alvogen, has been under the leadership and guidance of Lin since 2016.
MyCartis said Thursday it will engage in a novel point-of-need diagnostic solution named Antelope Dx, in its strategy to innovate novel immunodiagnostic technologies.
In the world of great discoveries that cure or add a positive element to our everyday existence, the invention of microbeads hasn’t proven to be one of them. Not alone in its quick rise to popularity and slow journey to extinction, the microbead is just one of numerous products rushed to market before its long term effects are uncovered.
Denali Therapeutics has started dosing Parkinson’s disease patients with its therapeutic candidate for slowing the progression of disease, in a…
Silence Therapeutics and Alnylam Pharmaceuticals have settled for royalty on net sales of Onpattro in EU, the companies said in separate press releases Monday, noting they will dismiss court proceedings
The sale of antifungal Cresemba (isavuconazole) in the United States by Astellas Pharma, kicked off CHF 10 million (€8.84M) payment…
ValiRx journey of bringing closer to market its leading anti-cancer therapeutic VAL201 for patients with hormone-sensitive and hormone-resistant prostate cancer, took a…
Stada said Thursday it increases its indirect shareholding in the Vietnamese pharmaceutical company Pymepharco JSC to 72 percent, with a…